Overview
Eijiro Shimada practices in Fukuoka, Japan. Shimada is rated as an Advanced expert by MediFind in the treatment of Chondrosarcoma. Their top areas of expertise are Ollier Disease, Maffucci Syndrome, Chondroma, and Adult Soft Tissue Sarcoma.
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Chondrosarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Maffucci SyndromeShimada isDistinguished. Learn about Maffucci Syndrome.
- Ollier DiseaseShimada isDistinguished. Learn about Ollier Disease.
- Advanced
- Adult Soft Tissue SarcomaShimada isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ChondromaShimada isAdvanced. Learn about Chondroma.
- ChondrosarcomaShimada isAdvanced. Learn about Chondrosarcoma.
- Experienced
- Bone TumorShimada isExperienced. Learn about Bone Tumor.
- FibrosarcomaShimada isExperienced. Learn about Fibrosarcoma.
- Lung MetastasesShimada isExperienced. Learn about Lung Metastases.